147 related articles for article (PubMed ID: 15947553)
1. Serum hepatitis B virus DNA levels differentiating inactive carriers from patients with chronic hepatitis B.
Seo Y; Yoon S; Truong BX; Kato H; Hamano K; Kato M; Yano Y; Katayama M; Ninomiya T; Hayashi Y; Kasuga M
Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):753-7. PubMed ID: 15947553
[TBL] [Abstract][Full Text] [Related]
2. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.
Chu CJ; Hussain M; Lok AS
Hepatology; 2002 Dec; 36(6):1408-15. PubMed ID: 12447866
[TBL] [Abstract][Full Text] [Related]
3. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
4. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
Manesis EK; Papatheodoridis GV; Sevastianos V; Cholongitas E; Papaioannou C; Hadziyannis SJ
Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
[TBL] [Abstract][Full Text] [Related]
5. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B.
Lindh M; Horal P; Dhillon AP; Norkrans G
J Viral Hepat; 2000 Jul; 7(4):258-67. PubMed ID: 10886534
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hepatitis B viraemia levels in patients with HBeAg-negative chronic hepatitis B virus infection.
Atay AE; Seven G; Yalcin K; Pasa S; Degertekin H
J Int Med Res; 2012; 40(5):1891-6. PubMed ID: 23206472
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatitis B virus (HBV) DNA levels at different stages of clinical course in patients with chronic HBV infection in an endemic area.
Heo J; Baik TH; Kim HH; Kim GH; Kang DH; Song GA; Cho M; Yang US
J Korean Med Sci; 2003 Oct; 18(5):686-90. PubMed ID: 14555821
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
[TBL] [Abstract][Full Text] [Related]
10. Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.
Assy N; Beniashvili Z; Djibre A; Nasser G; Grosovski M; Nseir W
World J Gastroenterol; 2009 Jun; 15(24):3025-31. PubMed ID: 19554656
[TBL] [Abstract][Full Text] [Related]
11. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
Chu CM; Chen YC; Tai DI; Liaw YF
Clin Gastroenterol Hepatol; 2010 Jun; 8(6):535-40. PubMed ID: 20304099
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
Feld JJ; Ayers M; El-Ashry D; Mazzulli T; Tellier R; Heathcote EJ
Hepatology; 2007 Oct; 46(4):1057-70. PubMed ID: 17654702
[TBL] [Abstract][Full Text] [Related]
13. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ
Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing different stages of hepatitis B infection using a competitive polymerase chain reaction assay.
Changotra H; Dwivedi A; Nayyar AK; Sehajpal PK
Indian J Med Microbiol; 2008; 26(2):138-42. PubMed ID: 18445949
[TBL] [Abstract][Full Text] [Related]
15. Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay.
Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Valdes A; Galimany R; Esteban R; Guardia J
J Viral Hepat; 2001 Nov; 8(6):465-71. PubMed ID: 11703579
[TBL] [Abstract][Full Text] [Related]
16. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
Kumar M; Sarin SK; Hissar S; Pande C; Sakhuja P; Sharma BC; Chauhan R; Bose S
Gastroenterology; 2008 May; 134(5):1376-84. PubMed ID: 18471514
[TBL] [Abstract][Full Text] [Related]
17. Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.
Shao J; Wei L; Wang H; Sun Y; Zhang LF; Li J; Dong JQ
World J Gastroenterol; 2007 Apr; 13(14):2104-7. PubMed ID: 17465456
[TBL] [Abstract][Full Text] [Related]
18. Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.
Yim SY; Um SH; Jung JY; Seo YS; Yim HJ; Ryu HS; Chun HJ; Jeen YT; Kim CD; Keum B; Lee HS
J Clin Gastroenterol; 2014 Feb; 48(2):166-71. PubMed ID: 24045280
[TBL] [Abstract][Full Text] [Related]
19. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
[TBL] [Abstract][Full Text] [Related]
20. Correlation of HBV DNA PCR and HBeAg in hepatitis B carriers.
Hussain AB; Karamat KA; Anwar M; Kazmi SY; Tariq WU
J Coll Physicians Surg Pak; 2004 Jan; 14(1):18-20. PubMed ID: 14764255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
